
Research Ethics Protocol Assessment
Evaluate research protocols against bioethical frameworks and generate IRB-ready assessments
What You Can Do
You can conduct comprehensive ethical audits of research protocols before IRB submission, identifying framework gaps in risk mitigation, informed consent language, and participant protections. The skill applies established bioethical reasoning to surface ethical tensions early, generates structured ethical analyses that accelerate review cycles, and helps you articulate defensible ethical justifications for complex study design decisions—particularly valuable when navigating conflicts between study rigor and participant safety, or when designing protocols for vulnerable populations.
Features
Evaluates informed consent adequacy, voluntariness protections, and capacity considerations for study populations
Systematically weighs risks against anticipated benefits using standardized frameworks to justify risk acceptability
Identifies equitable participant selection, fair burden distribution, and post-trial access considerations across vulnerable groups
Maps protocol elements against Common Rule, ICH-GCP, and discipline-specific standards (e.g., FDA, OHRP guidance)
Produces structured ethical justifications and language recommendations for complex consent scenarios
Flags tensions between study objectives and participant protections, with mitigation strategies
Addresses ethical variations across jurisdictions and institutional contexts for coordinated studies
Applies enhanced protections and additional safeguards specific to at-risk or marginalized populations
Example Output
Example 1: Phase 2 Treatment Deferral Study
- Autonomy Finding: Consent adequately discloses deferral duration and comparison arm risks; recommend 24-hour reflection period and comprehension assessment
- Risk-Benefit: Anticipated benefit magnitude (40% response rate improvement) justifies 8-week deferral; non-maleficence enhanced by weekly safety monitoring
- Recommendation: Approve with condition: add rescue clause for deteriorating participants
Example 2: Digital Health Real-World Data Study
- Justice Concern: Data collection skews toward high-income urban populations; underrepresents rural and low-connectivity participants
- Autonomy Gap: Re-consent language silent on secondary research use; recommend layered consent approach
- Regulatory Note: HIPAA Business Associate agreements required; state privacy law compliance unclear
- Recommendation: Revise sampling strategy and consent template; obtain privacy law opinion before submission
Example 3: Community Surveillance Protocol
- Beneficence vs. Justice Tension: Study benefits aggregate public health knowledge but imposes surveillance burden on marginalized community
- Stakeholder Engagement: Recommend community advisory board co-design of data governance and benefit-sharing agreements
- Mitigation: Propose data access limitations, community-controlled publication rights, and capacity-building commitments
What's Included
- SKILL.md: Complete protocol assessment framework with timing guidance and regulatory context
- Bioethical Framework Checklist: Structured evaluation template for autonomy, beneficence, non-maleficence, and justice across protocol elements
- IRB-Ready Documentation Template: Formatted ethical analysis document with findings, gaps, and recommendations organized for IRB reviewer efficiency
- Vulnerable Population Addendum: Enhanced safeguard protocols and consent modifications for pediatric, cognitively impaired, economically disadvantaged, and other protected populations
- Consent Language Generator Guide: Examples and templates for complex scenarios (adaptive trials, deception, deferral, real-world data, post-trial access)
Who It's For
- Bioethicists and ethics consultants — Conducting rapid ethical audits and generating structured assessments for IRB committees
- Research coordinators and protocol developers — Building ethical justifications into protocol design during development phases
- IRB staff and chair leadership — Structuring ethical analyses to accelerate review and consensus-building across review committees
- Clinical trial sponsors and CROs — Pre-submission ethical vetting for multi-site or high-risk studies to reduce review cycles and rejections
- Academic researchers in public health, behavioral, and social sciences — Designing protocols that balance methodological rigor with participant protections in vulnerable or underserved populations
Best For
- Pre-submission protocol vetting — Ethical audits during development to identify gaps before formal IRB submission
- Vulnerability and risk assessment — Evaluating protocols involving children, cognitive impairment, economic disadvantage, or other protected population characteristics
- Consent design and review — Developing ethically sound informed consent language for complex interventions, adaptive designs, or secondary research uses
- Multi-site ethical harmonization — Addressing ethical and regulatory variations across institutions or jurisdictions for coordinated studies
- Stakeholder disagreement resolution — Structuring ethical arguments when researchers, sponsors, IRBs, or communities differ on risk acceptability or benefit allocation







